TY - JOUR
T1 - Homozygous mutation in NUP107 leads to microcephaly with steroid-resistant nephrotic condition similar to Galloway-Mowat syndrome
AU - Rosti, Rasim Ozgur
AU - Sotak, Bethany N.
AU - Bielas, Stephanie L.
AU - Bhat, Gifty
AU - Silhavy, Jennifer L.
AU - Aslanger, Ayca Dilruba
AU - Altunoglu, Umut
AU - Bilge, Ilmay
AU - Tasdemir, Mehmet
AU - Yzaguirrem, Amanda D.
AU - Musaev, Damir
AU - Infante, Sofia
AU - Thuong, Whitney
AU - Marin-Valencia, Isaac
AU - Nelson, Stanley F.
AU - Kayserili, Hulya
AU - Gleeson, Joseph G.
N1 - Publisher Copyright:
© Article author(s).
PY - 2017/6/1
Y1 - 2017/6/1
N2 - Background Microcephaly with nephrotic syndrome is a rare co-occurrence, constituting the Galloway-Mowat syndrome (GAMOS), caused by mutations in WDR73 (OMIM: 616144). However, not all patients harbour demonstrable WDR73 deleterious variants, suggesting that there are other yet unidentified factors contributing to GAMOS aetiology. Methods Autozygosity mapping and candidate analysis was used to identify deleterious variants in consanguineous families. Analysis of patient fibroblasts was used to study splicing and alterations in cellular function. Results In two consanguineous families with five affected individuals from Turkey with a GAMOS-like presentation, we identified a shared homozygous variant leading to partial exon 4 skipping in nucleoporin, 107- KD(NUP107). The founder mutation was associated with concomitant reduction in NUP107 protein and in the obligate binding partner NUP133 protein, as well as density of nuclear pores in patient cells. Conclusion Recently, NUP107 was suggested as a candidate in a family with nephrotic syndrome and developmental delay. Other NUP107-reported cases had isolated renal phenotypes. With the addition of these individuals, we implicate an allele-specific critical role for NUP107 in the regulation of brain growth and a GAMOS-like presentation.
AB - Background Microcephaly with nephrotic syndrome is a rare co-occurrence, constituting the Galloway-Mowat syndrome (GAMOS), caused by mutations in WDR73 (OMIM: 616144). However, not all patients harbour demonstrable WDR73 deleterious variants, suggesting that there are other yet unidentified factors contributing to GAMOS aetiology. Methods Autozygosity mapping and candidate analysis was used to identify deleterious variants in consanguineous families. Analysis of patient fibroblasts was used to study splicing and alterations in cellular function. Results In two consanguineous families with five affected individuals from Turkey with a GAMOS-like presentation, we identified a shared homozygous variant leading to partial exon 4 skipping in nucleoporin, 107- KD(NUP107). The founder mutation was associated with concomitant reduction in NUP107 protein and in the obligate binding partner NUP133 protein, as well as density of nuclear pores in patient cells. Conclusion Recently, NUP107 was suggested as a candidate in a family with nephrotic syndrome and developmental delay. Other NUP107-reported cases had isolated renal phenotypes. With the addition of these individuals, we implicate an allele-specific critical role for NUP107 in the regulation of brain growth and a GAMOS-like presentation.
UR - https://www.scopus.com/pages/publications/85019686740
U2 - 10.1136/jmedgenet-2016-104237
DO - 10.1136/jmedgenet-2016-104237
M3 - Article
C2 - 28280135
AN - SCOPUS:85019686740
SN - 0022-2593
VL - 54
SP - 399
EP - 403
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
IS - 6
ER -